##gff-version 3
##sequence-region P31513 1 532
P31513	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9224773;Dbxref=PMID:9224773	
P31513	UniProtKB	Chain	2	532	.	.	.	ID=PRO_0000147654;Note=Dimethylaniline monooxygenase [N-oxide-forming] 3	
P31513	UniProtKB	Transmembrane	510	530	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P31513	UniProtKB	Nucleotide binding	9	13	.	.	.	Note=FAD;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9HFE4	
P31513	UniProtKB	Nucleotide binding	40	41	.	.	.	Note=FAD;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9HFE4	
P31513	UniProtKB	Nucleotide binding	60	61	.	.	.	Note=NADP;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9HFE4	
P31513	UniProtKB	Nucleotide binding	61	62	.	.	.	Note=FAD;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9HFE4	
P31513	UniProtKB	Nucleotide binding	195	198	.	.	.	Note=NADP;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9HFE4	
P31513	UniProtKB	Binding site	32	32	.	.	.	Note=FAD;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9HFE4	
P31513	UniProtKB	Modified residue	401	401	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P97501	
P31513	UniProtKB	Natural variant	24	24	.	.	.	ID=VAR_042705;Note=Modest increase in catalytic efficiency toward trimethylamine%2C methimazole%2C ethylenethiourea and sulindac. E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17050781;Dbxref=PMID:17050781	
P31513	UniProtKB	Natural variant	32	32	.	.	.	ID=VAR_037306;Note=In TMAU. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12893987;Dbxref=dbSNP:rs72549320,PMID:12893987	
P31513	UniProtKB	Natural variant	52	52	.	.	.	ID=VAR_008146;Note=In TMAU. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10479479;Dbxref=dbSNP:rs72549321,PMID:10479479	
P31513	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_042706;Note=Loss of activity. N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17050781;Dbxref=PMID:17050781	
P31513	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_037307;Note=In TMAU%3B more than 90%25 reduction in catalytic efficiency toward trimethylamine%2C benzydamine and methyl p-tolyl sulfide. N->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11191884,ECO:0000269|PubMed:17531949;Dbxref=dbSNP:rs72549322,PMID:11191884,PMID:17531949	
P31513	UniProtKB	Natural variant	66	66	.	.	.	ID=VAR_002423;Note=In TMAU%3B loss of activity%3B affects FAD binding. M->I;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10338091,ECO:0000269|PubMed:17531949,ECO:0000269|PubMed:9536088;Dbxref=dbSNP:rs72549323,PMID:10338091,PMID:17531949,PMID:9536088	
P31513	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_015364;Note=D->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12527699,ECO:0000269|Ref.4;Dbxref=dbSNP:rs12072582,PMID:12527699	
P31513	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_002424;Note=In TMAU%3B 90%25 reduction in catalytic efficiency toward trimethylamine and benzydamine%3B 34%25 reduction in catalytic efficiency toward methyl p-tolyl sulfide%3B nearly no effect on affinity for these substrates. P->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11191884,ECO:0000269|PubMed:17531949,ECO:0000269|PubMed:9536088;Dbxref=dbSNP:rs72549326,PMID:11191884,PMID:17531949,PMID:9536088	
P31513	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_002425;Note=35%25%2C 45%25 and 71%25 increase in catalytic efficiency toward trimethylamine%2C benzydamine and methyl p-tolyl sulfide%2C respectively. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10479479,ECO:0000269|PubMed:12527699,ECO:0000269|PubMed:17050781,ECO:0000269|PubMed:17531949,ECO:0000269|PubMed:9536088,ECO:0000269|Ref.4;Dbxref=dbSNP:rs2266782,PMID:10479479,PMID:12527699,PMID:17050781,PMID:17531949,PMID:9536088	
P31513	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_018345;Note=D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15618753;Dbxref=dbSNP:rs529940450,PMID:15618753	
P31513	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_018346;Note=R->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15618753,ECO:0000269|Ref.4;Dbxref=dbSNP:rs28363549,PMID:15618753	
P31513	UniProtKB	Natural variant	257	257	.	.	.	ID=VAR_002426;Note=65%25 increase in catalytic efficiency toward trimethylamine and 60%25 reduction toward benzydamine and methyl p-tolyl sulfide. V->M;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12527699,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:17050781,ECO:0000269|PubMed:17531949,ECO:0000269|PubMed:9536088,ECO:0000269|Ref.4;Dbxref=dbSNP:rs1736557,PMID:12527699,PMID:15489334,PMID:17050781,PMID:17531949,PMID:9536088	
P31513	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_014845;Note=V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.4;Dbxref=dbSNP:rs2066530	
P31513	UniProtKB	Natural variant	308	308	.	.	.	ID=VAR_002427;Note=16%25 reduction in catalytic efficiency toward trimethylamine and 40%25 increase toward benzydamine and methyl p-tolyl sulfide. E->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10479479,ECO:0000269|PubMed:17050781,ECO:0000269|PubMed:17531949,ECO:0000269|PubMed:9536088,ECO:0000269|Ref.4;Dbxref=dbSNP:rs2266780,PMID:10479479,PMID:17050781,PMID:17531949,PMID:9536088	
P31513	UniProtKB	Natural variant	360	360	.	.	.	ID=VAR_015365;Note=L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12527699,ECO:0000269|Ref.4;Dbxref=dbSNP:rs28363581,PMID:12527699	
P31513	UniProtKB	Natural variant	362	362	.	.	.	ID=VAR_014846;Note=E->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12527699,ECO:0000269|Ref.4;Dbxref=dbSNP:rs2066532,PMID:12527699	
P31513	UniProtKB	Natural variant	387	387	.	.	.	ID=VAR_008147;Note=In TMAU. R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10479479;Dbxref=dbSNP:rs72549331,PMID:10479479	
P31513	UniProtKB	Natural variant	416	416	.	.	.	ID=VAR_042707;Note=2-fold decrease in affinity for trimethylamine%3B 3-fold decrease in catalytic efficiency toward methimazole%3B 3-fold increase in catalytic efficiency toward sulindac%3B 30%25 increase in catalytic efficiency toward ethylenethiourea. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17050781;Dbxref=dbSNP:rs774785217,PMID:17050781	
P31513	UniProtKB	Natural variant	434	434	.	.	.	ID=VAR_037308;Note=In TMAU%3B profoundly alters enzyme function. M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11191884;Dbxref=dbSNP:rs72549332,PMID:11191884	
P31513	UniProtKB	Natural variant	492	492	.	.	.	ID=VAR_008145;Note=In TMAU%3B loss of activity%3B affects FAD binding. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10338091,ECO:0000269|PubMed:11191884,ECO:0000269|PubMed:17531949;Dbxref=dbSNP:rs72549334,PMID:10338091,PMID:11191884,PMID:17531949	
P31513	UniProtKB	Natural variant	503	503	.	.	.	ID=VAR_015366;Note=G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12527699;Dbxref=dbSNP:rs72549335,PMID:12527699	
P31513	UniProtKB	Sequence conflict	298	298	.	.	.	Note=S->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P31513	UniProtKB	Sequence conflict	369	369	.	.	.	Note=I->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P31513	UniProtKB	Sequence conflict	400	405	.	.	.	Note=PSMEDM->GPFYGKTL;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P31513	UniProtKB	Sequence conflict	410	410	.	.	.	Note=N->I;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P31513	UniProtKB	Sequence conflict	418	419	.	.	.	Note=KW->ANG;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P31513	UniProtKB	Sequence conflict	444	445	.	.	.	Note=KP->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P31513	UniProtKB	Sequence conflict	449	449	.	.	.	Note=W->M;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P31513	UniProtKB	Sequence conflict	454	454	.	.	.	Note=D->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P31513	UniProtKB	Sequence conflict	461	462	.	.	.	Note=VY->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P31513	UniProtKB	Sequence conflict	478	478	.	.	.	Note=Q->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P31513	UniProtKB	Sequence conflict	486	486	.	.	.	Note=I->M;Ontology_term=ECO:0000305;evidence=ECO:0000305	
